Search research articles
Contact Us
Filters
Showing results (81-90 of 140) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
September 22, 2022
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections
Noah Brazer, Mary Kate Morris, Venice Servellita, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 28, 2021
Triangulating Evidence to Infer Pathways that Influence Ebola Virus Disease-Related Stigma and Clinical Findings among Survivors: An Observational Cohort Study
J Daniel Kelly, Moses Badio, Clara Drew, et al.
Open Forum Infectious Diseases
|
March 10, 2022
Association of Lower Exposure Risk With Paucisymptomatic/Asymptomatic Infection, Less Severe Disease, and Unrecognized Ebola Virus Disease: A Seroepidemiological Study
J Daniel Kelly, Raphael G Frankfurter, Jacqueline M Tavs, et al.
Epidemics
|
August 6, 2019
Estimating the impact of violent events on transmission in Ebola virus disease outbreak, Democratic Republic of the Congo, 2018-2019
S Rae Wannier, Lee Worden, Nicole A Hoff, et al.
The Lancet. Microbe
|
March 13, 2025
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control study
Mosoka P Fallah, Collin Van Ryn, J Soka Moses, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
Mohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
BMJ Global Health
|
November 12, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
Mohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
Amanda M Buck, Amelia N Deitchman, Saki Takahashi, et al.
Open Forum Infectious Diseases
|
August 28, 2023
Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron Era
Sarah A Goldberg, Scott Lu, Miguel Garcia-Knight, et al.
JCI Insight
|
April 7, 2022
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
Matthew S Durstenfeld, Michael J Peluso, J Daniel Kelly, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 140) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
September 22, 2022
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections
Noah Brazer, Mary Kate Morris, Venice Servellita, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 28, 2021
Triangulating Evidence to Infer Pathways that Influence Ebola Virus Disease-Related Stigma and Clinical Findings among Survivors: An Observational Cohort Study
J Daniel Kelly, Moses Badio, Clara Drew, et al.
Open Forum Infectious Diseases
|
March 10, 2022
Association of Lower Exposure Risk With Paucisymptomatic/Asymptomatic Infection, Less Severe Disease, and Unrecognized Ebola Virus Disease: A Seroepidemiological Study
J Daniel Kelly, Raphael G Frankfurter, Jacqueline M Tavs, et al.
Epidemics
|
August 6, 2019
Estimating the impact of violent events on transmission in Ebola virus disease outbreak, Democratic Republic of the Congo, 2018-2019
S Rae Wannier, Lee Worden, Nicole A Hoff, et al.
The Lancet. Microbe
|
March 13, 2025
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control study
Mosoka P Fallah, Collin Van Ryn, J Soka Moses, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
Mohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
BMJ Global Health
|
November 12, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
Mohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
Amanda M Buck, Amelia N Deitchman, Saki Takahashi, et al.
Open Forum Infectious Diseases
|
August 28, 2023
Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron Era
Sarah A Goldberg, Scott Lu, Miguel Garcia-Knight, et al.
JCI Insight
|
April 7, 2022
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
Matthew S Durstenfeld, Michael J Peluso, J Daniel Kelly, et al.
Page
of 14